Polar Capital Global Healthcare Trust announces Andrew Fleming and Jeremy Whitley to its Board as upcoming Independent Directors

– UK, London –  Polar Capital Global Healthcare Trust plc (LON: PCGH) today announced the appointment of Andrew Fleming and Jeremy Whitley as new independent Non-executive Directors with effect from 1 December 2019.

James Robinson, the Chairman, said: “We are very pleased that both Andrew and Jeremy have agreed to join the Board and we look forward to benefitting from their extensive experience and complementary skills.”

In addition to the above, both Andrew and Jeremy will also be appointed as Non-executive Directors of the Company’s subsidiary, PCGH ZDP plc, with the same effective date.

About Andrew Fleming

Andrew Fleming recently left Waverton, where he was chief executive and retired as chair of the board of JP Morgan Japanese Investment Trust plc in December 2018. Mr Fleming began his career at Gartmore before joining ABN Amro and latterly Kames Capital where he was CEO and CIO.

About Jeremy Whitley

Jeremy Whitley is currently a non-executive director and chairman of the audit committee of The Scottish Oriental Smaller Companies Trust plc. With effect from 1 February 2020, Mr Whitley will also join the board of JP Morgan Indian Investment Trust plc as a non-executive director. Mr Whitley was formerly Head of UK and European Equities at Aberdeen Asset Management, a position he held from 2009 to 2017. Previous roles there include being a Senior Investment Manager on the Global Equities team as well as the Asian equities team, based in Singapore, where he was lead manager of the Edinburgh Dragon Trust. He began his investment career at SG Warburg & Co in 1988.

For more information: https://www.polarcapitalhealthcaretrust.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.